SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey L. Henken who wrote (1100)6/3/1998 8:00:00 PM
From: mantle7  Read Replies (1) of 2887
 
And, if you read the article you posted you will note that the focus is on the hospital personnel, not patients. Hospitals are more interested in saving money than a 1 in 1 million (exageration) allergy victim. In addition many, many catheters are made out of P.E. and not latex. So please tell me again why there is a big market. Don't bother with hollow, bold statements: back it up with facts and statistics. Just how big is the demand for non-allergenic catheters in the U.S. and in which surgical procedures will they be used? How many of those procedures are done a year?

Also, please explain just why AVE would be interested in ABMI's catheters? AVe's stent is already mounted on a catheter. Just where is AVE's product portfolio weak?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext